Acquisition of the “Espace Shopping Hydrion” retail park Ascencio acquires today 100% of the shares in Arlimmo SA, the full owner of the “Espace Shopping Hydrion” retail park in Arlon, a leading retail asset centrally-located in a dynamic cross-border area. Covering an area of 33,000 m², the site is home to some forty well-known national and international retailers (Action, HEMA, Carrefour Market, Basic Fit, etc.) and boasts a 100% occupancy rate, generating annual rental income of around EUR 4.5 million. Ideally located in the heart of the “golden triangle” of Belgium, France and Luxembourg, Espace Shopping Hydrion benefits from excellent accessibility and a large high-spending catchment area, making it a key retail centre in the region. Operating for more than 20 years and with a solid track record...

BRATISLAVA, Slovakia, June 10, 2026 (GLOBE NEWSWIRE) — WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, recently outlined plans to commercialize its Level 4 autonomous vehicle portfolio in Slovakia during a high-level meeting with His Excellency Mr. Robert Fico, Prime Minister of Slovakia in Bratislava. The meeting was also attended by Jozef Ráž, Minister of Transport of Slovakia; Ľubomír Slovák, and Director General of the Strategy and Planning Section at the Ministry of Transport of Slovakia.WeRide Robotaxi GXR has arrived in Slovakia  The meeting was held at the invitation of DiusAI, the local partner of ELEVATE Slovakia, a national multi-stakeholder initiative that aims to establish a safe, regulatory-ready framework for autonomous mobility. During the meeting, WeRide showcased its global...

Live demonstrations highlight real-time power control, efficiency and system performance across AI data center, EV and high-power applications NUREMBERG, Germany, June 10, 2026 (GLOBE NEWSWIRE) — Skyworks Solutions, Inc. (Nasdaq: SWKS), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions, will showcase its latest power and gate driver technologies at PCIM Europe 2026, with a focus on enabling next-generation AI data centers, electric vehicle (EV) platforms and industrial high-power applications. “AI is re-architecting data center power delivery, driving the industry toward higher-voltage DC architectures and creating new requirements for efficiency, functional safety, observability and real-time control,” said Mario Battello, vice president of product line management at Skyworks....

PRESS RELEASE — JUNE 10, 2026 Nabil Bennis Appointed Head of Valuation and Investment Strategy Performance Monitoring at Wendel Wendel announces the appointment of Nabil Bennis as Head of Valuation and Investment Strategy Performance Monitoring. This new responsibility reflects the continued development of Wendel Investment Managers, Wendel’s third-party private asset management business, initiated three years ago. In addition to his role as Valuation Manager, Nabil is now responsible for monitoring the performance of Wendel Investment Managers’ fund portfolios. He will therefore maintain reporting to the Finance Department for valuation activities, while reporting to Cyril Marie, Deputy Chief Executive Officer, Strategy and Corporate Development, for the performance monitoring of the funds. Nabil, 36, began his career in business valuation...

Paris, June 10, 2026 Press release URW enters into conditional agreement to acquire remaining 50% of Westfield UTC Unibail-Rodamco-Westfield (“URW” or “the Group”) has entered into a conditional agreement to acquire from its joint venture partner the remaining 50% stake in Westfield UTC, an A++ rated flagship asset located in San Diego, California. The acquisition consideration of c. $705 Mn will comprise a combination of cash and up to 2.6 million new shares to be issued by URW1 (without lock-up restrictions) and is subject to further adjustment for closing costs and reimbursements. Completion of the transaction is subject to URW’s share price and customary closing conditions. The definitive composition of consideration will be announced at closing. The transaction excludes certain land parcels that will continue to be owned in partnership. Subject...

Louvain-la-Neuve, Belgium, June 10, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for the treatment of cancer, today announced a sponsored research agreement with The University of Texas MD Anderson Cancer Center aimed at advancing health economics evidence generation for proton beam therapy. This research will focus on generating robust clinical and economic evidence to better quantify the value of proton therapy compared with other treatment modalities. The research will be led by Dr. Matthew Ning, MD, MPH, Assistant Professor of Radiation Oncology and Dr. Iakovos Toumazis, Assistant Professor of Health Services Research and co-lead for UT MD Anderson’s Institute for Data Science in Oncology’s decision analytics for health focus...

WISeKey’s SEALCOIN Subsidiary Accelerates Space-Based Blockchain Infrastructure Following Strategic $4 Million Investment Commitment New Funding from The Hashgraph Group and WISeKey Supports Expansion of the QAIT-Powered Space Economy and Next-Generation Satellite Transactions Geneva, Switzerland –June 10, 2026 — WISeKey International Holding Ltd (SIX: WIHN; NASDAQ: WKEY), a global leader in cybersecurity, digital identity and IoT, today announced that its subsidiary SEALCOIN which focuses on decentralized physical internet with DePIN technology and houses the development of the SEALCOIN platform secured $4 million strategic investment, including a $1 million commitment from The Hashgraph Group (THG) and a $3 million commitment from WISeKey, with the objective to accelerate the integration of the SEALCOIN ecosystem into the rapidly emerging...

Huw van Steenis to Join as European Economic & Policy Strategist Sarah Jenkins to Join as Head of Government Affairs, Europe LONDON and NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Huw van Steenis will join the firm as a Partner and European Economic & Policy Strategist, and that Sarah Jenkins will join the firm as a Managing Director and Head of Government Affairs for Europe. Both newly created positions start in August and are based in London, Apollo’s European headquarters. Van Steenis has spent more than 25 years in leadership and senior advisory roles for global financial institutions, with a focus on strategy, policy and economic research. He was most recently the Vice Chair of Oliver Wyman, and before that served as a senior advisor to the CEO of UBS as well as to the Bank...

Coop Pank’s financial results in May 2026:In May, number of the bank’s clients increased by 1,700 and number of active clients increased by 700. By the end of the month number of clients reached 234,500 and number of active clients reached 111,100. Over the year, customer base has grown by 9%. Volume of the bank’s customer deposits increased by 57 million euros in May, reaching 2.15 billion euros by the end of month. Deposits of corporate customers increased by 19 million and deposits of private customers increased by 1 million euros. The volume of deposits attracted from international platforms increased by 37 million euros. Over the year, volume of bank deposits increased by 23%. The bank’s loan portfolio increased by 41 million euros over the month and reached 2.22 billion euros by the end of May. The home loan...

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped. This decision follows an interim analysis by an independent data monitoring committee, which determined that the MOBILIZE study is unlikely to provide sufficient efficacy. No safety signals related to riliprubart were identified as part of this interim analysis. The continuation of other ongoing studies with riliprubart, including the VITALIZE phase 3 study (clinical study identifier: NCT06290141) in IVIg-treated patients with CIDP, will be evaluated accordingly. Sanofi...